Literature DB >> 21906831

GLP-1 agonist treatment: implications for diabetic retinopathy screening.

Lakshminarayanan Varadhan1, Tracy Humphreys, Christian Hariman, Adrian B Walker, George I Varughese.   

Abstract

Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21906831     DOI： 10.1016/j.diabres.2011.08.017

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  14 in total

1.  Bariatric surgery and diabetic retinopathy: a pilot analysis.

Authors:  Lakshminarayanan Varadhan; Tracy Humphreys; Adrian B Walker; Chandra V N Cheruvu; George I Varughese
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

Review 2.  New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy.

Authors:  Mercy Saw; Vincent W Wong; I-Van Ho; Gerald Liew
Journal:  Eye (Lond)       Date:  2019-06-21       Impact factor: 3.775

Review 3.  Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making.

Authors:  Gerhard H Scholz; Holger Fleischmann
Journal:  Ther Adv Endocrinol Metab       Date:  2014-10       Impact factor: 3.565

4.  Monitoring of Diabetic Retinopathy in relation to Bariatric Surgery: a Prospective Observational Study.

Authors:  Troels Brynskov; Caroline Schmidt Laugesen; Annette Lykke Svenningsen; Andrea Karen Floyd; Torben Lykke Sørensen
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

5.  Activation of retinal Müller cells in response to glucose variability.

Authors:  Fabiana Picconi; Mariacristina Parravano; Francesca Sciarretta; Chiara Fulci; Michela Nali; Simona Frontoni; Monica Varano; Anna Maria Caccuri
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

Review 6.  The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Authors:  Douglas Cheung; Noah J Switzer; David Ehmann; Christopher Rudnisky; Xinzhe Shi; Shahzeer Karmali
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

7.  Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults.

Authors:  Tiansheng Wang; Jin-Liern Hong; Emily W Gower; Virginia Pate; Seema Garg; John B Buse; Til Stürmer
Journal:  Diabetes Care       Date:  2018-07-16       Impact factor: 19.112

Review 8.  The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?

Authors:  Dora M Gorman; Carel W le Roux; Neil G Docherty
Journal:  Diabetes Metab J       Date:  2016-09-27       Impact factor: 5.376

Review 9.  Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence.

Authors:  Daiji Kawanami; Keiichiro Matoba; Kazunori Sango; Kazunori Utsunomiya
Journal:  Int J Mol Sci       Date:  2016-07-29       Impact factor: 5.923

Review 10.  Effects of Incretin-Based Therapies on Diabetic Microvascular Complications.

Authors:  Yu Mi Kang; Chang Hee Jung
Journal:  Endocrinol Metab (Seoul)       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.